Pharma Deals Review, Vol 2005, No 55 (2005)

Font Size:  Small  Medium  Large

AstraZeneca Takes Stake in Cambridge Antibody Technology alongside Antibody Discovery Alliance

Business Review Editor

Abstract


AstraZeneca and Cambridge Antibody entered into a strategic alliance for the joint discovery and development of human monoclonal antibodies in the field of inflammatory and respiratory diseases.

Full Text: pdf

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.